Dr. Fauci would later mimic this successful model to populate key drug and vaccine approval committees in FDA, CDC, and at the Institute of Medicine (IOM) with his Pharma PIs, giving him, and his Pharma partners, complete, vertically integrated control over the drug approval process from molecule to market.
